The aim of this study is to provide a comprehensive overview of three key technologies, MRI, micro-ultrasound, and prostate-specific membrane antigen (PSMA) PET scans, and how they can improve prostate cancer detection and management. This evidence concerns the gene FOLH1 and prostate carcinoma.